NCT04550494 2026-03-19Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsNational Cancer Institute (NCI)Phase 2 Recruiting36 enrolled
NCT04704661 2026-03-18Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialNational Cancer Institute (NCI)Phase 1 Recruiting51 enrolled